Why the study?
Hypertension prevalence in Africa is rising but remains underdiagnosed and poorly controlled, with only 22% of known hypertensive individuals in Kenya on treatment and 51.7% controlled.
A hypertension programme in Kenya demonstrated poor 12-month retention (12%) and suboptimal blood pressure control (48.6%), highlighting the need for targeted screening and improved retention strategies.
Answers are grounded in this paper and cite their sources.
Low retention and control rates in this Kenyan cohort suggest implementation barriers; leaves open effective retention strategies for similar programs.
BACKGROUND: Prevalence of hypertension in Africa is rising but it remains underdiagnosed and poorly controlled. In Kenya, only 22% of individuals known to have hypertension were on treatment, and only 51.7% were controlled. This study will assess screening outcomes, retention and blood pressure (BP) control of a hypertension programme in Kenya. DESIGN: This was a retrospective cohort study using data routinely collected between 2015 and 2018. All patients aged >18 years screened and treated in the programme were included. RESULTS: Of 663,028 screening encounters, 70.4% were female; the median age was 34 years. Overall, 19% of the study population, mainly males and older persons, had high BP higher rates. Of 66,981 patients started on treatment, the majority were females (71.2%); the median age was 55 years. Only 12% of patients were reported as having been retained after 12 months, and 48.6% of patients on treatment 10.5-13.5 months after enrolment had controlled BP. Older age and treatment at primary care level were associated with better retention and females had better BP control. CONCLUSIONS: The programme screened primarily females and younger individuals at lower risk. Retention was poor and close to half of patients retained had controlled BP. Hypertension programmes should target high-risk individuals, decentralise treatment, incorporate retention strategies and improve longitudinal data management.
No takes yet. Share an insight, caveat, or question.
Mbau et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: